Results for tag: "Topical Hemostat"

In the field of wound care, the Topical Hemostat market encompasses a range of products designed to promote hemostasis, which is the process of blood clot formation to stop bleeding. These products are particularly crucial in surgical procedures, trauma situations, and in treating individuals with clotting deficiencies. Topical hemostats are available in various forms, including granular powders, films, pads, and gels. They work by different mechanisms; some provide a physical barrier to bleeding, while others promote the aggregation of platelets or catalyze the clotting process through biological or synthetic materials. The choice of topical hemostat may depend on factors such as the nature and location of the wound, the extent of bleeding, and any underlying patient conditions. With ongoing research and development, the market has seen the introduction of more advanced hemostatic agents that offer improved efficacy, faster action, and greater biocompatibility. Several companies are prominent in the Topical Hemostat market, maintaining a strong presence in the wound care sector. Notable players include Johnson & Johnson (with its ETHICON subsidiary), Baxter International Inc., Becton, Dickinson and Company (BD), CryoLife Inc., Pfizer Inc., and Z-Medica, LLC. These companies engage in the development, manufacturing, and distribution of hemostatic products, and often invest in research to advance the field of topical hemostasis further. Show Less Read more